Heparin Sodium recalls
Heparin Sodium products have been recalled 5 times, most recently on 15 Mar 2023. The recalling company is usually Hospira. The most common reason is sterility.
Total recalls5since 2014
Last 12 months0reported
Class I120% of total
Ongoing0latest 15 Mar 2023
Recalls per month, last 24 months
click a bar for that monthSeverity split
Class I 1 20%Class II 4 80%Class III 0 0%
Why heparin sodium is recalled
Companies
Product types
By year
All heparin sodium recalls, newest first
5 total| Reported | Class | Recall | Company | Reason | Where |
|---|---|---|---|---|---|
| Drug | CLASS II | Heparin Sodium Injection, USP, 20,000 USP units per mL recalledHeparin Sodium | Sagent Pharmaceuticals | Other | Nationwide |
| Drug | CLASS II | Heparin Sodium 2,000, USP Units, per (2 USP Units/mL) recalled by PfizerHeparin Sodium | Pfizer | Sterility | Nationwide |
| Drug | CLASS I | Heparin Sodium, 1000 USP Heparin Units recalled by HospiraHeparin Sodium | Hospira | Particulate Matter | Nationwide |
| Drug | CLASS II | Heparin Sodium Injection, USP 10,000 USP units recalledHeparin Sodium | Fresenius Kabi USA | Potency & Assay | Nationwide |
| Drug | CLASS II | Heparin Sodium 2000 USP Heparin Units recalled by HospiraHeparin Sodium | Hospira | Sterility | Nationwide |
About this list
Records come from FDA enforcement reports and USDA FSIS notices, grouped by normalised name. A company operating under several names may appear more than once.